Cefprozil Powder, For Suspension
Product Images NDC 68180-273
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cefprozil (NDC 68180-273). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
250ml-50 mL (F2cfb43d 9704 49ca 8eae 97327e62044d 02)
This text appears to be a description of a pharmaceutical product with the National Drug Code (NDC) 68180-273-01. It is a dry powder that, when reconstituted, results in a cefprozil suspension for oral use. The reconstituted suspension contains 250 mg/5 ml of cefprozil USP. It is advised to shake the suspension well before use and store it in the refrigerator after reconstitution. The product should be discarded after 4 days. The manufacturer is Lupin Pharmaceuticals, and the product is made in India. The text also includes instructions for pharmacists on how to prepare the suspension and information for phenylketonurics.*
250 -75 mL (F2cfb43d 9704 49ca 8eae 97327e62044d 03)
This is a pharmaceutical product with the NDC code 68180-273-02. It is a suspension containing cefprozil USP equivalent to 250 mg of anhydrous cefprozil per teaspoonful (5 mL). It is for oral use only and needs to be shaken well before using. The accompanying instructions guide pharmacists on how to prepare the suspension for dispensing and storing. The product is manufactured by Lupin Limited in India and distributed by Lupin Pharmaceuticals, Inc. in the United States.*
250-100 mL (F2cfb43d 9704 49ca 8eae 97327e62044d 04)
This text is a set of instructions for preparing a suspension medication by adding water to a dry powder. It includes details such as the NDC number, manufacturer, storage instructions, dosage information, and special considerations for phenylketonurics. The user is advised to shake the suspension well before use and to store it in the refrigerator after reconstitution. The text ends with a reminder that the product is for oral use only.*
Image (F2cfb43d 9704 49ca 8eae 97327e62044d 132 1)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.